A Biologically Optimized PEG-IFN-α2 Variant Exhibits Potent Anti-HBV and Immunomodulatory Efficacy
- DOI
- 10.1080/22221751.2026.2761206
- Published
- 2026-11-06
- Container
- Emerging Microbes & Infections
- Publisher
- Informa UK Limited
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1080/22221751.2026.2761206,
title = {A Biologically Optimized PEG-IFN-α2 Variant Exhibits Potent Anti-HBV and Immunomodulatory Efficacy},
author = {Asha Ashuo and Jianyu Ye and Ruohan Jia and Yumeng Li and Yansong Chen and Zhong Fang and Michael Zhiyan Wang and Jieliang Chen and Zhenghong Yuan},
year = {2026},
journal = {Emerging Microbes \& Infections},
doi = {10.1080/22221751.2026.2761206},
url = {https://doi.org/10.1080/22221751.2026.2761206}
}RIS
TY - JOUR TI - A Biologically Optimized PEG-IFN-α2 Variant Exhibits Potent Anti-HBV and Immunomodulatory Efficacy AU - Asha Ashuo AU - Jianyu Ye AU - Ruohan Jia AU - Yumeng Li AU - Yansong Chen AU - Zhong Fang AU - Michael Zhiyan Wang AU - Jieliang Chen AU - Zhenghong Yuan PY - 2026 JO - Emerging Microbes & Infections DO - 10.1080/22221751.2026.2761206 UR - https://doi.org/10.1080/22221751.2026.2761206 ER -
APA
Ashuo, A., Ye, J., Jia, R., Li, Y., Chen, Y., Fang, Z., Wang, M. Z., Chen, J., & Yuan, Z. (2026). A Biologically Optimized PEG-IFN-α2 Variant Exhibits Potent Anti-HBV and Immunomodulatory Efficacy. Emerging Microbes & Infections. https://doi.org/10.1080/22221751.2026.2761206
Source records
- crossref · retrieved 2026-11-10T14:49:30.612Z